5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.41▼ | 0.43▼ | 0.43▼ | 0.43▼ | 0.47▼ |
MA10 | 0.42▼ | 0.43▼ | 0.43▼ | 0.44▼ | 0.53▼ |
MA20 | 0.43▼ | 0.43▼ | 0.43▼ | 0.49▼ | 0.90▼ |
MA50 | 0.43▼ | 0.44▼ | 0.44▼ | 0.58▼ | 2.11▼ |
MA100 | 0.45▼ | 0.45▼ | 0.47▼ | 0.97▼ | 6.29▼ |
MA200 | 0.45▼ | 0.49▼ | 0.50▼ | 1.40▼ | 13.46▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.002▼ | -0.001▼ | 0.002▲ | 0.107▲ |
RSI | 32.579▼ | 37.530▼ | 39.165▼ | 33.774▼ | 24.375▼ |
STOCH | 0.240▼ | 44.432 | 33.628 | 18.345▼ | 5.413▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -97.349▼ | -99.644▼ |
CCI | -136.463▼ | -208.256▼ | -179.425▼ | -97.095 | -82.398 |
Tuesday, May 20, 2025 05:06 AM
Developed by ALX Oncology's protein engineers utilizing the Company's proprietary topoisomerase I inhibitor payload and linker-payload platform, ALX2004 has been rigorously designed to maximize the ...
|
Monday, May 19, 2025 09:00 AM
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept ...
|
Wednesday, May 14, 2025 12:59 PM
In a recent transaction, Jaume Pons, the President and Chief Scientific Officer of ALX Oncology Holdings Inc. (NASDAQ:ALXO), sold ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/05/25 | 0.4288 | 0.4458 | 0.4051 | 0.409 | 357,598 |
20/05/25 | 0.44 | 0.449 | 0.4211 | 0.4288 | 444,286 |
19/05/25 | 0.4295 | 0.4579 | 0.4124 | 0.4313 | 535,817 |
16/05/25 | 0.4357 | 0.4506 | 0.4281 | 0.4374 | 328,241 |
15/05/25 | 0.4556 | 0.4701 | 0.4207 | 0.4358 | 342,941 |
14/05/25 | 0.485 | 0.5346 | 0.436 | 0.4594 | 549,087 |
13/05/25 | 0.44 | 0.481 | 0.44 | 0.481 | 537,473 |
12/05/25 | 0.4223 | 0.4488 | 0.4171 | 0.4352 | 450,360 |
09/05/25 | 0.4754 | 0.48 | 0.41 | 0.4223 | 814,069 |
08/05/25 | 0.497 | 0.497 | 0.441 | 0.4602 | 841,421 |
|
|
||||
|
|
||||
|
|